Bell’s palsy is an acute, idiopathic, unilateral paralysis or paresis of the facial nerve (cranial nerve VII) resulting in sudden, usually temporary weakness or complete paralysis of all the muscles of facial expression on the affected side. It is the most common cause of acute facial nerve palsy, accounting for approximately 51% of all CN VII palsy cases. It is a diagnosis of exclusion — other identifiable causes of facial palsy (Lyme disease, Ramsay Hunt syndrome, tumor, stroke, trauma) must first be ruled out. The nerve becomes inflamed and swollen — most likely triggered by reactivation of herpes simplex virus (HSV-1) — within the tight bony facial canal, causing ischemia and demyelination. From a medical-coding perspective, Bell’s palsy documentation must clarify: Laterality (though G51.0 does not require a laterality code — it is a single billable code for the condition) Concurrent ocular complications (lagophthalmos, paralytic ectropion, exposure keratopathy) Complicating conditions (synkinesis, crocodile tear syndrome) Diagnostic studies performed (EMG, ENoG, imaging) Treatment rendered (corticosteroids, antivirals, eye protection, PT/OT)
These distinctions affect additional diagnosis code assignment, CPT selection, and medical necessity documentation. The condition is named after Sir Charles Bell (1774-1842), a Scottish surgeon and anatomist who first described the anatomy of the facial nerve and its associated palsy in 1821. The word palsy derives from Old French paralisie, itself from Latin/Greek paralysis (a loosening, disabling).
Bell’s: Named after Sir Charles Bell (1774-1842), Scottish surgeon and anatomist who described the condition and the facial nerve anatomy; the facial nerve is sometimes called the “nerve of Bell” in his honor
palsy: From Old French paralisie → Medieval Latin paralisis → Greek paralysis (παράλυσις), meaning “a loosening” or “a disabling,” derived from paralyein (“to disable on one side”), combining para- (“beside, alongside”) + lyein (“to loosen”)
Bell’s → Eponym honoring Sir Charles Bell, describer of CN VII anatomy and this condition (1821)
palsy → Greek/Latin paralysis, meaning “a loosening, a disabling”
Bell’s palsy literally means “Bell’s loosening/disabling [of the face].”
Note: The facial nerve (cranial nerve VII) was described in detail by Bell, who distinguished it from the trigeminal nerve (CN V). Prior to Bell’s anatomical work, facial paralysis was poorly understood and not distinguished from other palsy types. The eponym was established by the medical community after his 1821 publication “On the Nerves of the Face.”
Palsy - General medical term for paralysis or uncontrolled movement; used in cerebral palsy, shaking palsy (Parkinson’s), etc.
Electroneuronography (ENoG) - Nerve conduction study of the facial nerve; key diagnostic test; CPT 92516
Synkinesis - Involuntary co-movement of facial muscles; late complication of Bell’s palsy; treated with botulinum toxin
Common Clinical Indications / Causes
Viral etiology (most widely accepted): Reactivation of herpes simplex virus type 1 (HSV-1) at the geniculate ganglion within the facial canal — triggers inflammation, edema, ischemia, and demyelination of CN VII
“EMG of facial muscles” (→ CPT 95868 bilateral or 95867 unilateral)
“Ramsay Hunt ruled out — no ear vesicles” (supports G51.0 vs. B02.21)
These help confirm diagnosis, support medical necessity, identify complications to code additionally, and justify ancillary CPT codes.
Coder’s Notes
G51.0 is a single, fully billable code — there are no laterality subsets under G51.0 in ICD-10-CM; laterality is not required for this code; do NOT look for G51.01 or G51.02 — they do not exist
Bell’s palsy is a diagnosis of exclusion — the clinical documentation must support that other causes were ruled out; if Lyme disease is confirmed, use A69.22 not G51.0; if herpes zoster, use B02.21 (Ramsay Hunt) not G51.0
Ocular complications MUST be coded additionally — lagophthalmos (H02.20-) and paralytic ectropion (H02.151-H02.156) are separate billable diagnoses that support medical necessity for eye care and oculoplastic referrals; do not leave these off the claim
Sequencing for oculoplastic procedures: When ectropion repair is performed secondary to Bell’s palsy, G51.0 sequences first as the underlying cause; paralytic ectropion (H02.152 or H02.155) codes second as the manifestation
97032 Electrical stimulation: Covered under Medicare NCD 160.15 specifically for Bell’s palsy — document the diagnosis code G51.0 to support coverage
92516 ENoG: Performed to evaluate extent of nerve degeneration; guides prognosis and surgical candidacy; bill with G51.0 as the indication
Late complications (synkinesis, crocodile tear syndrome) code to G51.8 — not G51.0; these represent sequelae of aberrant nerve regeneration after Bell’s palsy resolution
Botulinum toxin for synkinesis: Use 64612 (chemodenervation, eccrine glands) or 64615 (chemodenervation, muscles innervated by facial nerve) with G51.8 as the diagnosis; not G51.0
Modifier -RT / -LT — while G51.0 has no laterality in the ICD-10-CM code, laterality modifiers may be required on CPT codes for electrodiagnostic studies when billed unilaterally (95867)
Modifier -25 — if E/M and ENoG or electrical stimulation are performed on the same date, document the separately identifiable evaluation and management service
Crystal's MCW Coder Hub